共 50 条
High-Throughput Analyses of Therapeutic Antibodies Using High-Field Asymmetric Waveform Ion Mobility Spectrometry Combined with SampleStream and Intact Protein Mass Spectrometry
被引:2
|作者:
Shi, Rachel Liuqing
[3
]
Dillon, Michael A.
[1
]
Compton, Philip D.
[2
]
Sawyer, William S.
[3
]
Thorup, John R.
[3
]
Kwong, Mandy
[3
]
Chan, Pamela
[3
]
Chiu, Cecilia P. C.
[1
]
Li, Ran
[4
]
Yadav, Rajbharan
[4
]
Lee, Genee Y.
[5
]
Gober, Joshua G.
[6
]
Li, Zhiyu
[7
]
Elsohly, Adel M.
[6
]
Ovacik, Ayse Meric
[4
]
Koerber, James T.
[1
]
Spiess, Christoph
[1
]
Josephs, Jonathan L.
[3
]
Tran, John C.
[3
]
机构:
[1] Genentech Inc, Dept Antibody Engn, South San Francisco, CA 94080 USA
[2] Integrated Prot Technol, Evanston, IL 60201 USA
[3] Genentech Inc, Dept Biochem & Cellular Pharmacol, South San Francisco, CA 94080 USA
[4] Genentech Inc, Dept Preclin & Translat Pharmacokinet & Pharmacody, South San Francisco, CA 94080 USA
[5] Genentech Inc, Dept Mol Oncol, South San Francisco, CA 94080 USA
[6] Genentech Inc, Dept Prot Chem, South San Francisco, CA 94080 USA
[7] WuXi AppTec Inc, DMPK Serv Dept, Shanghai 200131, Peoples R China
关键词:
BISPECIFIC ANTIBODIES;
AFFINITY CAPTURE;
IN-VIVO;
BIOANALYSIS;
DRUG;
BIOTRANSFORMATION;
QUANTITATION;
VALIDATION;
DISCOVERY;
SERUM;
D O I:
10.1021/acs.analchem.3c03158
中图分类号:
O65 [分析化学];
学科分类号:
070302 ;
081704 ;
摘要:
Intact protein mass spectrometry (MS) coupled with liquid chromatography was applied to characterize the pharmacokinetics and stability profiles of therapeutic proteins. However, limitations from chromatography, including throughput and carryover, result in challenges with handling large sample numbers. Here, we combined intact protein MS with multiple front-end separations, including affinity capture, SampleStream, and high-field asymmetric waveform ion mobility spectrometry (FAIMS), to perform high-throughput and specific mass measurements of a multivalent antibody with one antigen-binding fragment (Fab) fused to an immunoglobulin G1 (IgG1) antibody. Generic affinity capture ensures the retention of both intact species 1Fab-IgG1 and the tentative degradation product IgG1. Subsequently, the analytes were directly loaded into SampleStream, where each injection occurs within similar to 30 s. By separating ions prior to MS detection, FAIMS further offered improvement in signal-overnoise by similar to 30% for denatured protein MS via employing compensation voltages that were optimized for different antibody species. When enhanced FAIMS transmission of 1Fab-IgG1 was employed, a qualified assay was established for spiked-in serum samples between 0.1 and 25 mu g/mL, resulting in similar to 10% accuracy bias and precision coefficient of variation. Selective FAIMS transmission of IgG1 as the degradation surrogate product enabled more sensitive detection of clipped species for intact 1Fab-IgG1 at 5 mu g/mL in serum, generating an assay to measure 1Fab-IgG1 truncation between 2.5 and 50% with accuracy and precision below 20% bias and coefficient of variation. Our results revealed that the SampleStream-FAIMS-MS platform affords high throughput, selectivity, and sensitivity for characterizing therapeutic antibodies from complex biomatrices qualitatively and quantitatively.
引用
收藏
页码:17263 / 17272
页数:10
相关论文